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Abstract 
Background; Warts are common epidermal growths caused by human papillomavirus that often cause 
significant discomfort and embarrassment. Current treatment options include topical therapies, cryotherapy, laser 
vaporization, and surgical excision. Objective: To compare the efficacy of oral zinc sulphate versus topical 
application of salicylic acid (16.7%) & lactic acid (16.7%) combination in the treatment of plantar warts. 
Material and Methods; Group A, having 78 patients, was given oral zinc sulphate (10 mg/kg/day) in 2 or 3 
divided doses. In group B, 78 patients were advised to apply a combination of salicylic (16.7%) & lactic acid 
(16.7%) once at night daily. In group A, using oral zinc sulphate, the treatment was given for two months and 
follow up continued for next 1 month. In group B, the topical preparation was also continued for 2 months or till 
the complete removal of warts. Results; Of these 156 study cases, 94 (60.3 %) were male patients while 62 (39.7 
%) were female patients. Mean age of our study cases was 34.42 ± 9.87 years. Monthly family income up to Rs. 
30000 was noted in 68 (43.6%) while 88 (56.4%) had monthly family income more than Rs. 30000. Mean 
weight of our study cases was 61.96 ± 10.29 kilograms. Mean height of our study cases 161.24 ± 12.23 
centimeters. Mean BMI of our study cases was 26.52± 1.87 kg/m
2
 and obesity was present in 31 (19.9%) of our 
study cases. Mean no. of lesions was noted to be 5.30 ± 2.45 lesions (with minimum no. of lesions was 4 and 
maximum no. of lesions was 10) and 131 (84%) had up to 5 lesions. Mean duration of disease was 4.69 ± 1.61 
months and 112 (71.8 %) had disease duration up to 6 months. Efficacy was noted in 110 (70.5 %). Efficacy in 
group A was noted to be 83.3 % and in group B was 57.7 % (p= 0.001). Conclusion; Our study results support 
the use of oral Zinc Sulphate in the treatment of plantar warts as compared to the salicylic acid (16.7%) and 
lactic acid (16.7%) combination. Efficacy of Zinc Sulphate was significantly higher when compared with 
combination therapy and it was found to be safe and reliable mode of treatment having no side effects were 
observed in our study. Use of Zinc Sulphate can help to reduce chance of recurrence and disease morbidity. 
Being cost effective, it provides cheaper mode of treatment as compared with cryotherapy which is quite 
expensive which will provide economic relief to our large poor population. Early treatment can help patients to 
maintain routine daily lives and physical activities such as sports without any pain and side effects.  
Keywords; Plantar warts, Zinc Sulphate, Salicylic acid, lactic acid.  
 
INTRODUCTION: 
Wart is a mucocutaneous disease that develops as a result of proliferation of infected skin or mucosal cells with 
human papilloma virus (HPV).
1 
They range in size from less than 1mm to over 1cm and can form large masses 
when confluent.
2 
. Different clinical forms of warts include common warts, palmoplantar warts, flat warts, 
filiform warts and anogenital warts.
3
 Human papillomaviruses (HPVs) are a group of more than 100 DNA 
viruses that infect human epithelial cells.
4
 The majority of common warts are caused by HPV types 1,2,4,27,57 
and plane warts by 3 and 10
5
.                                                                                                                         A 
plantar wart (also called verruca plantaris) is a lesion that appears on the plantar surface of foot as a small, 
shining, sago-grain papule which soon assumes the typical appearance of a sharply-defined rounded lesion with 
a rough keratotic surface surrounded by a smooth collar of thickened horn. Warts occur at any age, but are 
common among children. It is estimated that 7 - 10% of the United States (US) population have plantar warts. 
The virus can survive many months without a host, making it highly contagious. Plantar warts are caused by 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.51, 2018 
 
 
96 
 
infection with human papilloma virus types 1, 2, 4 and 63. The virus attacks the skin through direct contact, 
entering via tiny cuts and abrasions in the stratum corneum. The common sites of plantar warts are beneath 
pressure points (the heel or the metatarsal heads). The duration of plantar warts is very variable. Spontaneous 
regression occurs sooner in children. In adults, warts may persist for years 
6
. Plantar warts (PW) may sometimes 
resolve spontaneously, with their natural course usually being shorter in children than adults, although resolution 
may take several years
7-9
. The treatment of PW has involved several different modes, including ablative therapy 
and other options that modify the immune response 
10-13
.
 
The topical application of salicylic and lactic acid combination in a collodion is a common form of treatment 
with once daily application. It is an effective treatment option with few side effects. It is used as an initial 
therapy for treatment of plantar warts with minimum cost and minimal pain. Salicylic acid causes keratolysis 
thus helps in removing the thickened epidermis. Oral zinc sulphate is also an effective therapy in the treatment of 
warts. Zinc has an important effect on the immune system and it has been used as an immunomodulator to treat a 
variety of skin disorders. Efficacy with oral Zinc sulphate is reported to be 82 % while 62% topical application 
of salicylic acid (16.7%) & lactic acid (16.7%) combination 
6
. 
 
MATERIAL AND METHODS: 
Aged between 20-60 years, having plantar warts of either sex having warts (more than 3) for less than 6 months 
duration were included in our study.  
Pregnant and lactating women, not willing to participate and patients who had taken any therapy for warts 
previously, having known drug allergy were not included in our study. Patients was randomly allocated in to two 
groups by lottery method. The patients were given mixed envelops marked as group A and group B and was 
asked to pick any one of them and they were placed in respective group as indicated by their envelop. Group A, 
having 78 patients, was given oral zinc sulphate (10 mg/kg/day) in two or three divided doses. In group B, 78 
patients were advised to apply a combination of salicylic (16.7%) & lactic acid (16.7%) once at night daily. In 
group A, using oral zinc sulphate, the treatment was given for two months and follow up continued for next 1 
month. In group B, the topical preparation was also continued for 2 months or till the complete removal of wart 
(if before two months) and follow up was extended up to 1 month after treatment.  At the end of 4 weeks both 
groups were evaluated for treatment efficacy. All data was entered using software SPSS version 22. 
 
RESULTS; 
Our study registered a total of 156 study cases meeting inclusion criteria of our study from OPD of department 
of Dermatology, Nishtar Hospital, Multan. Of these 156 study cases, 94 (60.3 %) were male patients while 62 
(39.7 %) were female patients. Mean age of our study cases was 34.42 ± 9.87 years (with minimum age was 21 
years while maximum age was 54 years). Mean age of our study cases in group A was 34.62 ± 9.95 years while 
in group B was 34.23 ± 9.85 years ( p = 0.809). Our study results have reported that majority of our study cases 
i.e. 103 (66%%) belonged to age group of 20 – 40 years of age. Of these 156 study cases, 55 (35.3%) were from 
rural areas while 101 (64.7%) were from urban areas. Monthly family income up to Rs. 30000 was noted in 68 
(43.6%) while 88 (56.4%) had monthly family income more than Rs. 30000. Mean weight of our study cases 
was 61.96 ± 10.29 kilograms (with minimum weight was 54 kilograms and maximum was 94 Kilograms). Mean 
height of our study cases 161.24 ± 12.23 centimeters. Mean BMI of our study cases was 26.52± 1.87 kg/m
2
 and 
obesity was present in 31 (19.9%) of our study cases. Mean no. of lesions was noted to be 5.30 ± 2.45 lesions 
(with minimum no. of lesions was 4 and maximum no. of lesions was 10) and 131 (84%) had up to 5 lesions 
(Table No. 6).  
Mean duration of disease was 4.69 ± 1.61 months and 112 (71.8 %) had disease duration up to 6 months. 
Efficacy was noted in 110 (70.5 %). Efficacy in group A was noted to be 83.3 % and in group B was 57.7 % (p= 
0.001).   
 
DISCUSSION; 
Cutaneous warts are benign epidermal proliferations caused by Human Papilloma viruses (HPV) 
14
. Viral warts 
are common afflictions, affecting mostly children and young adults. Humoral immunity provides sufficient 
protection against HPV infection
15
. If the infection does develop, innate and adaptive cell mediated immunity is 
important for the eventual elimination of the infection
16-19
. Our study registered a total of 156 study cases 
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meeting inclusion criteria of our study from OPD of department of Dermatology, Nishtar Hospital, Multan. Of 
these 156 study cases, 94 (60.3 %) were male patients while 62 (39.7 %) were female patients. Such male gender 
preponderance has also been reported by Raza et al 
15
 who reported 69 % male gender predominance which is 
similar to our study results. While a study conducted Bruggink et al 
20
 reported 56% female gender 
preponderance which is different from our study results.  
Mean age of our study cases was 34.42 ± 9.87 years (with minimum age was 21 years while maximum age was 
54 years). Mean age of our study cases in group A was 34.62 ± 9.95 years while in group B was 34.23 ± 9.85 
years ( p = 0.809). Our study results have reported that majority of our study cases i.e. 103 (66%%) belonged to 
age group of 20 – 40 years of age. Raza et al 15 also reported viral warts being predominating 20 – 30 years age 
group which is similar to our study results. A study conducted by Cockayne et al 
21 
reported 24.3 years mean age 
of the patients with warts which is similar to our study results.  
Of these 156 study cases, 55 (35.3%) were from rural areas while 101 (64.7%) were from urban areas. Monthly 
family income up to Rs. 30000 was noted in 68 (43.6%) while 88 (56.4%) had monthly family income more than 
Rs. 30000. Mean weight of our study cases was 61.96 ± 10.29 kilograms (with minimum weight was 42 
kilograms and maximum was 85 grams). Mean height of our study cases 161.24 ± 12.23 centimeters. Mean BMI 
of our study cases was 26.52± 1.87 kg/m
2
 and obesity was present in 31 (19.9%) of our study cases.  
Mean no. of lesions was noted to be 5.30 ± 2.45 lesions (with minimum no. of lesions was 4 and maximum no. 
of lesions was 10) and 131 (84%) had up to 5 lesions. A study conducted by Cockayne et al 
21
 documented mean 
no. of lesions were 4.0 ±  6.6 which is in compliance with that of our study results.  
Mean duration of disease was 4.69 ± 1.61 months and 112 (71.8 %) had disease duration up to 6 months.  Raza 
et al 
15
 and Cockayne et al 
21 
reported similar results.  
Efficacy was noted in 110 (70.5 %). Efficacy in group A was noted to be 83.3 % and in group B was 57.7 % (p= 
0.001). A study conducted by Salman et al 
 6 
reported efficacy with oral Zinc sulphate to be 82 % while 62% 
topical application of salicylic acid (16.7%) & lactic acid (16.7%) combination. These findings are close to our 
study results.  
 
CONCLUSION; 
Our study results support the use of oral Zinc Sulphate in the treatment of plantar warts as compared to the 
salicylic acid (16.7%) and lactic acid (16.7%) combination. Efficacy of Zinc Sulphate was significantly higher 
when compared with combination therapy and it was found to be safe and reliable mode of treatment having no 
side effects were observed in our study. Use of Zinc Sulphate can help to reduce chance of recurrence and 
disease morbidity. Being cost effective, it provides cheaper mode of treatment as compared with cryotherapy 
which is quite expensive which will provide economic relief to our large poor population. Early treatment can 
help patients to maintain routine daily lives and physical activities such as sports without any pain and side 
effects.  
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